This trial is testing whether a combination of two drugs, megestrol acetate and metformin, is more effective than megestrol acetate alone in preventing the progression of uterine pre-cancer (endometrial intraepithelial neoplasia) to endometrial cancer.
1 Primary · 1 Secondary · Reporting Duration: Up to 42 days post surgery
50 Total Participants · 2 Treatment Groups
Primary Treatment: Megestrol Acetate · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: